Extra Radiation Dose Prevents Breast Cancer Return in Young Women

	Tweet

Women 40 years and younger with early-stage breast cancer who receive an additional high dose of radiation (boost dose) after undergoing breast-conserving surgery (lumpectomy) and standard radiation treatment are almost twice as likely to be free of cancer 10 years after treatment compared to those who don’t receive the boost dose, according to a large European study presented at the Plenary I session on October 29, 2007, at the American Society for Therapeutic Radiology and Oncology’s 49th Annual Meeting in Los Angeles. Although younger women benefitted most from an extra dose of radiation, the findings show that women of all ages who had a boost dose of radiation after standard treatment were more likely to be cancer-free over a 10-year period.

The study involved 5,318 women who underwent lumpectomies and whole breast radiation treatment as part of their breast conserving therapy for Stage I and Stage II breast cancer and were evaluated 10 years later.

Researchers wanted to determine if a boost dose of radiation following this treatment would decrease the risk of breast cancer recurrence. In addition to this, a sub-group of 1,725 patients were evaluated to find out the highest risk factors for localized breast cancer recurrence.

“The study found that the largest benefits of the boost dose of radiation after standard breast conserving treatment is seen in young women, who have a higher risk to breast cancer recurrence to begin with,” said Harry Bartelink, M.D., Ph.D., the senior author of the study and professor and radiation oncologist at The Netherlands Cancer Institute at Antoni van Leeuwenhoek Hospital in The Netherlands.

For patients with early stage breast cancer, the current standard treatment involves breast conserving surgery (lumpectomy), followed by radiation therapy to the breast over a six to eight week period to kill any remaining cancer cells. In this study, an additional boost of high-dose radiation was given after conventional radiation therapy to the lumpectomy site where the tumor was removed to potentially increase the chances of a cure.

With a lumpectomy, the surgeon removes the tumor, along with nearby healthy tissue. If the outside of the tumor, or margin, has cancer cells present, then it’s considered a positive margin. If it’s unclear, or a very small distance, then doctors call it a close margin. Women who have positive and close surgical margins are at a higher risk of breast cancer returning, compared to those who have negative margins that are free of cancer.

The study also found that early-stage breast cancer patients who were at a younger age are most likely to have their cancer come back (recurrence), particularly those who have positive surgical margins. This study and previous ones have shown that young patients with early-stage breast cancer have a higher risk of breast recurrence, compared to older patients because their cancer tends to be more aggressive.

The abstract, “The Impact Of Boost Dose And Margins On The Local Recurrence Rate In Breast Conserving Therapy: Results From The Eortc Boost- No Boost Trial,” will be presented in the Plenary I session at 2:00 p.m., Monday, October 29, 2007. To speak to the study author, Harry Bartelink, M.D., Ph.D., please call Beth Bukata or Nicole Napoli October 28-31, 2007, in the ASTRO Press Room

Source: American Society for Therapeutic Radiology and Oncology (ASTRO)

RELATED STORIES:
Chemo drugs for treating breast cancer may cause changes in cognitive function   Breast cancer rates fell with hormone therapy drop   Breast cancer rules rewritten in ‘landmark’ study   Should You Have a Mastectomy to Prevent Breast Cancer?   Breast cancer gene carriers need dual screening   Decision guide reduced uncertainty over breast cancer prevention, study finds   Drug Could Effectively Treat, Prevent the Spread of Breast Cancer   Einstein scientists find crucial molecule involved in spread of breast cancer   UB played major role in study on drug that reduces breast cancer in high-risk women   A pill a day gives renewed hope for breast cancer victims   Circulating tumor cells not linked to survival in newly diagnosed inflammatory breast cancer   3-D doppler ultrasound helps identify breast cancer   Peaches, plums induce deliciously promising death of breast cancer cells   ‘Fingerprinting’ Breast Cancer Cells   Breast Tenderness During HRT Linked to Elevated Cancer Risk   Teen drinking tied to breast disease   Racial disparities seen in male breast cancer survival   Mastectomy Mystery: Why It’s a Choice When Cancer Isn’t Evident   Study aims to find which breast cancer patients need chemotherapy   FDA Broadens Clearance For Agendia’s MammaPrint(R)   Resetting Biological Clock May Help Prevent Breast Cancer   Breast Cancer Rates Decline Most for Affluent White Women

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]